Abstract
Up to 70% of patients with cancer should be expected to experience pain during the cancer illness. This is clearly more likely as disease progresses. The World Health Organisation (WHO) cancer pain guidelines remain the key to following a simple and systematic approach to cancer pain control in approximately 80% of patients. This approach was never intended to be used in isolation of various non-pharmacological approaches, including tumouricidal therapies. However, lateral thought when managing challenging cancer-related pain becomes even more critical. This paper reviews the approach to the approximately 20% of patients who do not respond to the standard WHO three-step analgesic ladder approach and of course, by definition this means in practice those patients with severe pain which is not controlled by morphine or alternative strong opioids. Such cancer pain can be broadly categorised as opioid irrelevant pain, opioid partially responsive pain, opioid unresponsive pain or pain resulting from excess opioid.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carr DB, Goudas L, Balk E et al (2004) Evidence report on the treatment of pain in cancer patients. JNCI 32:23–31
Cherny N, Ripamonti C, Fallon MT et al (2001) Strategies to manage the adverse effects of oral morphine: the evidence. J Clin Oncol 19(9):2542–2554
Colvin L, Forbes K, Fallon MT (2006) Difficult pain. BMJ 332:1081–1083 6 May
Colvin L, Walley J, Duncan S, Fallon M (2006) Alterations in evoked sensory responses in cancer-induced bone pain (CIBP). British Pain Association, Harrogate Abstract 71
Donovan-Rodriguez T, Dickenson A, Urch C (2005) Gabapentin normalizes spinal neuronal responses that correlate with behaviour in a rat model of cancer-pain and regional anaesthesia. Anesthesiology 102(1):132–140
Fallon MT, Hanks G, Cherny N (2006) Principles of control of cancer pain. BMJ 332:1022–1024 29 April
Fallon MT, McConnell S (2006) The principles of cancer pain management. Clinical Medicine 6(2):136–139 March/April
Fallon MT (2005) The current situation with cancer pain. In: Justins D (ed) Pain 2005—an updated review. IASP, Seattle
Fallon MT (1997) Opioid rotation—does it have a role? Palliat Med 11(3):176–178
Fallon MT, Hanks GWC (1993) Opioid-resistant pain: sense or nonsense? Pain Clin 6:205–206
Walley J, Colvin L Fallon M (2006) Characterisation of malignant bone pain. In NCRI Conference, Birmingham, Abstract A62 http://www.ncri.org.uk/ncriconference/abstract/pdf/pdfs/NCRI2006_0544.pdf
WHO Guidelines (1996) Cancer pain relief, 2nd edn. World Health Organization, Geneva
Wong R, Wiffen PJ (2002) Bisphosphonates for the relief of pain secondary to bone metastasis. Cochrane Database Syst Rev (2), DOI 10.1002/14651858.CD002068
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00520-008-0458-5
Rights and permissions
About this article
Cite this article
Fallon, M. When morphine does not work. Support Care Cancer 16, 771–775 (2008). https://doi.org/10.1007/s00520-008-0402-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-008-0402-8